| American Journal of Cancer Research | |
| PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application | |
| Pu Xia1  Xiao-Yan Xu1  | |
| 关键词: Cancer stem cells; PI3K/Akt/mTOR signaling pathway; self-renew; tumor initiation; rapamycin; | |
| DOI : | |
| 学科分类:肿瘤学 | |
| 来源: e-Century Publishing Corporation | |
PDF
|
|
【 摘 要 】
Cancer stem cells (CSCs) are a subpopulation of tumor cells that possess unique self-renewal activity and mediate tumor initiation and propagation. The PI3K/Akt/mTOR signaling pathway can be considered as a master regulator for cancer. More and more recent studies have shown the links between PI3K/Akt/mTOR signaling pathway and CSC biology. Herein, we provide a comprehensive review on the role of signaling components upstream and downstream of PI3K/Akt/mTOR signaling in CSC. In addition, we also summarize various classes of small molecule inhibitors of PI3K/Akt/mTOR signaling pathway and their clinical potential in CSC. Overall, the current available data suggest that the PI3K/Akt/mTOR signaling pathway could be a promising target for development of CSC-target drugs.
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201912140867624ZK.pdf | 675KB |
PDF